Search all medical codes

Complication of immune effector cellular therapy, subsequent encounter

ICD10CM code

Similar Codes


ICD10CM codes

T80.82XD - Complication of immune effector cellular therapy, subsequent encounter
T80.82XA - Complication of immune effector cellular therapy, initial encounter
T80.82 - Complication of immune effector cellular therapy
T80.82XS - Complication of immune effector cellular therapy, sequela
T80.89XD - Other complications following infusion, transfusion and therapeutic injection, subsequent encounter
T80.90XD - Unspecified complication following infusion and therapeutic injection, subsequent encounter
T80.8XXD - Other complications following infusion, transfusion and therapeutic injection, subsequent encounter
T80.9XXD - Unspecified complication following infusion, transfusion and therapeutic injection, subsequent encou
T80.6XXD - Other serum reactions, subsequent encounter
T80.29XD - Infection following other infusion, transfusion and therapeutic injection, subsequent encounter

HCPCS codes

S9359 - Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administr
J9311 - Injection, rituximab 10 mg and hyaluronidase
J7599 - Immunosuppressive drug, not otherwise classified
S9338 - Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care
J0850 - Injection, cytomegalovirus immune globulin intravenous (human), per vial
Q2043 - Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leuk
G8482 - Influenza immunization administered or previously received
G9416 - Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the
J9227 - Injection, isatuximab-irfc, 10 mg
J9312 - Injection, rituximab, 10 mg

CPT4 codes

86849 - Unlisted immunology procedure
86153 - Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating t
38242 - Allogeneic lymphocyte infusions
88230 - Tissue culture for non-neoplastic disorders; lymphocyte
95199 - Unlisted allergy/clinical immunologic service or procedure
86644 - Antibody; cytomegalovirus (CMV)
90399 - Unlisted immune globulin
88239 - Tissue culture for neoplastic disorders; solid tumor
0538T - Chimeric antigen receptor T-cell (CAR-T) therapy; preparation of blood-derived T lymphocytes for tra
36515 - Therapeutic apheresis; with extracorporeal immunoadsorption and plasma reinfusion